Torrent Pharmaceuticals share news, announcements and annual reports
NSE: TORNTPHARMBSE: 500420Pharmaceuticals & BiotechnologyLarge Cap
Torrent Pharmaceuticals Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1994 on BSE, Nov 2002 on NSE
Last close ₹4,580.00up ₹23.00 (0.50%)BSE ₹4,564.10
Share price at the NSE close on 29 Oct 2026. Previous close ₹4,557.00.
29 Oct: open ₹4,540.00, high ₹4,610.90, low ₹4,525.30
52-week range of traded prices to 29 Oct 2026
₹3,532.60Low, 6 Nov 2025₹5,250.00High, 3 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,74,208 Cr61st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 82.02
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.48
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.83%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.76
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,20,05563.1% delivered
Torrent Pharmaceuticals shareholder meetings
75 filed, newest first. Page 1 of 2.
Sep 2026
7 Sep · Meeting
Aug 2026
5 Aug · Meeting
Jun 2026
23 Jun · Meeting
Apr 2026
Mar 2026
Jul 2025
29 Jul · Meeting
28 Jul · Meeting
Jul 2024
Jun 2024
29 Jun · Meeting
Nov 2023
27 Nov · Meeting
Oct 2023
26 Oct · Meeting
Aug 2023
Jul 2023
14 Jul · Meeting
Sep 2022
9 Sep · Meeting
Aug 2022
8 Aug · Meeting
Jul 2022
30 Jul · Meeting
29 Jul · Meeting
1 Jul · Meeting
May 2022
30 May · Meeting
Jul 2021
27 Jul · Meeting
Jul 2020
30 Jul · Meeting
Mar 2020
7 Mar · Meeting
7 Mar · Meeting
Feb 2020
4 Feb · Meeting
Jul 2019
25 Jul · Meeting
23 Jul · Meeting
Mar 2019
8 Mar · Meeting
8 Mar · Meeting
Feb 2019
4 Feb · Meeting
Aug 2018
13 Aug · Meeting
Jul 2018
Mar 2018
1 Mar · Meeting
Feb 2018
Jan 2018
27 Jan · Meeting
Aug 2017